How Psychedelics Are Combating Depression Symptoms

With depression numbers skyrocketing, the World Health Organization has identified the condition as a leading cause of disability. Anthony Lacavera joins Doug Drysdale, CEO of Cybin to learn how their company is seeking to improve classic psychedelics like psilocybin, which can remove depressive symptoms or addictive cravings, and discuss the nuances of drug development.